World Library  
Flag as Inappropriate
Email this Article

Serum amyloid A

Article Id: WHEBN0008253387
Reproduction Date:

Title: Serum amyloid A  
Author: World Heritage Encyclopedia
Language: English
Subject: High-density lipoprotein, Haemodialysis-associated amyloidosis, Familial renal amyloidosis, ITM2B, AA amyloidosis
Collection:
Publisher: World Heritage Encyclopedia
Publication
Date:
 

Serum amyloid A

Human Serum amyloid A1
Identifiers
Symbol SAA1
Entrez 6288
HUGO 10513
OMIM 104750
RefSeq NM_199161
UniProt P0DJI8
Other data
Locus Chr. 11 p15.1
Human Serum amyloid A2
Identifiers
Symbol SAA2
Entrez 6289
HUGO 10514
OMIM 104751
RefSeq NM_030754
UniProt P02735
Other data
Locus Chr. 11 p15.1-p14
Human Serum amyloid A3, pseudogene
Identifiers
Symbol SAA3P
Alt. symbols SAA3
Entrez 6290
HUGO 10515
UniProt P22614
Other data
Locus Chr. 11 p15.1-p14
Human Serum amyloid A4
Identifiers
Symbol SAA4
Alt. symbols C-SAA
Entrez 6291
HUGO 10516
OMIM 104752
RefSeq NM_006512
UniProt P35542
Other data
Locus Chr. 11 p15.1-p14

Serum amyloid A (SAA) proteins are a family of apolipoproteins associated with high-density lipoprotein (HDL) in plasma. Different isoforms of SAA are expressed constitutively (constitutive SAAs) at different levels or in response to inflammatory stimuli (acute phase SAAs). These proteins are produced predominantly by the liver.[1] The conservation of these proteins throughout invertebrates and vertebrates suggests that SAAs play a highly essential role in all animals.[2]

Acute-phase serum amyloid A proteins

Acute-phase serum amyloid A proteins (A-SAAs) are secreted during the acute phase of inflammation. These proteins have several roles, including the transport of cholesterol to the liver for secretion into the bile, the recruitment of immune cells to inflammatory sites, and the induction of enzymes that degrade extracellular matrix. A-SAAs are implicated in several chronic inflammatory diseases, such as amyloidosis, atherosclerosis, and rheumatoid arthritis.[3] Three acute-phase SAA isoforms have been reported in mice, called SAA1, SAA2, and SAA3. During inflammation, SAA1 and SAA2 are expressed and induced principally in the liver, whereas SAA3 is induced in many distinct tissues. SAA1 and SAA2 genes are regulated in liver cells by the proinflammatory cytokines IL-1, IL-6, and TNF-α. Both SAA1 and SAA2 are induced up to a 1000-fold in mice under acute inflammatory conditions following exposure to bacterial lipopolysaccharide (LPS).[3] Three A-SAA genes have also been identified in humans,[4] although the third gene, SAA3, is believed to represent a pseudogene that does not generate messenger RNA or protein.[5]

Serum amyloid A (SAA) is also an acute phase marker that responds rapidly. Similar to CRP, levels of acute-phase SAA increase within hours after inflammatory stimulus, and the magnitude of increase may be greater than that of CRP. Relatively trivial inflammatory stimuli can lead to SAA responses. It has been suggested that SAA levels correlate better with disease activity in early inflammatory joint disease than do ESR and CRP. Although largely produced by hepatocytes, more recent studies show that SAA is produced by adipocytes as well, and its serum concentration is associated with body mass index.[6]

Constitutive serum amyloid A proteins

A fourth SAA (SAA4) was identified in humans and is expressed constitutively in the liver and, thus, is defined as a constitutive SAA (C-SAA).[7] A similar protein that is now also called SAA4 has since been identified in the mouse; it had originally been designated SAA5.[8][9]

References

  1. ^ Uhlar CM, Whitehead AS (1999). "Serum amyloid A, the major vertebrate acute-phase reactant". Eur. J. Biochem. 265 (2): 501–23.  
  2. ^ Manley PN, Ancsin JB, Kisilevsky R (2006). "Rapid recycling of cholesterol: the joint biologic role of C-reactive protein and serum amyloid A". Med. Hypotheses 66 (4): 784–92.  
  3. ^ a b Zhang N, Ahsan MH, Purchio AF, West DB (2005). "Serum amyloid A-luciferase transgenic mice: response to sepsis, acute arthritis, and contact hypersensitivity and the effects of proteasome inhibition". J. Immunol. 174 (12): 8125–34.  
  4. ^ Betts JC, Edbrooke MR, Thakker RV, Woo P (1991). "The human acute-phase serum amyloid A gene family: structure, evolution and expression in hepatoma cells". Scand. J. Immunol. 34 (4): 471–82.  
  5. ^ Kluve-Beckerman B, Drumm ML, Benson MD (1991). "Nonexpression of the human serum amyloid A three (SAA3) gene". DNA Cell Biol. 10 (9): 651–61.  
  6. ^ Pincus MR, McPherson RA, Henry JB (2007). Henry's Clinical Diagnosis and Management by Laboratory Methods. Saunders Elsevier.  
  7. ^ Steel DM, Sellar GC, Uhlar CM, Simon S, DeBeer FC, Whitehead AS (1993). "A constitutively expressed serum amyloid A protein gene (SAA4) is closely linked to, and shares structural similarities with, an acute-phase serum amyloid A protein gene (SAA2)". Genomics 16 (2): 447–54.  
  8. ^ de Beer MC, Kindy MS, Lane WS, de Beer FC (1994). "Mouse serum amyloid A protein (SAA5) structure and expression". J. Biol. Chem. 269 (6): 4661–7.  
  9. ^ de Beer MC, de Beer FC, Gerardot CJ et al. (1996). "Structure of the mouse Saa4 gene and its linkage to the serum amyloid A gene family". Genomics 34 (1): 139–42.  
This article was sourced from Creative Commons Attribution-ShareAlike License; additional terms may apply. World Heritage Encyclopedia content is assembled from numerous content providers, Open Access Publishing, and in compliance with The Fair Access to Science and Technology Research Act (FASTR), Wikimedia Foundation, Inc., Public Library of Science, The Encyclopedia of Life, Open Book Publishers (OBP), PubMed, U.S. National Library of Medicine, National Center for Biotechnology Information, U.S. National Library of Medicine, National Institutes of Health (NIH), U.S. Department of Health & Human Services, and USA.gov, which sources content from all federal, state, local, tribal, and territorial government publication portals (.gov, .mil, .edu). Funding for USA.gov and content contributors is made possible from the U.S. Congress, E-Government Act of 2002.
 
Crowd sourced content that is contributed to World Heritage Encyclopedia is peer reviewed and edited by our editorial staff to ensure quality scholarly research articles.
 
By using this site, you agree to the Terms of Use and Privacy Policy. World Heritage Encyclopedia™ is a registered trademark of the World Public Library Association, a non-profit organization.
 


Copyright © World Library Foundation. All rights reserved. eBooks from Project Gutenberg are sponsored by the World Library Foundation,
a 501c(4) Member's Support Non-Profit Organization, and is NOT affiliated with any governmental agency or department.